Insiders Updates
Analysts predict EYPT shares will perform strongly in 2023
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. EyePoint Pharmaceuticals
Menu
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. EyePoint Pharmaceuticals
EyePoint Pharmaceuticals Inc’s filing revealed that its Director Zaderej Karen L. acquired Company’s shares for reported $29950.0 on May 19
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. EyePoint Pharmaceuticals
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
The NASDAQ’s 1.0% gain led the market yesterday, and the S&P 500 and DJIA posted fractional gains. After passing its
The S&P 500 pulled back from its newly acquired all-time high yesterday and 0.4% on the session. The NASDAQ also